Yi Sun

2PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 01, 2025
Tislelizumab and Hypofractionated Radiotherapy plus Nab-Paclitaxel/Gemcitabine as Conversion Therapy for BRPC/LAPC: A Phase II Trial with Dynamic Biomarker Monitoring.

Jiayao Ni, Yi Sun, Hao Cheng

|Jun 06, 2024
First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial.

Huizi Sha, Fan Tong, Jiayao Ni

Pageof 1

Frequent Collaborators

1 joint publications

Jiayao Ni

1 joint publications

Hao Cheng

1 joint publications

Xinyuan Bai

1 joint publications

Fan Tong